DRI Healthcare Trust (DHT.UN)
TSX
Closed
Aug 25, 2026
Day's Range
17.6852 wk Range
13.92Overview - DHT.UN - DRI Healthcare Trust
Key Statistics
Valuation
Enterprise Value
1.89B
P/E (Trailing)
‪155.70‬
P/E (Forward)
‪5.58‬
PEG Ratio
‪0.15‬
Price / Sales (TTM)
‪5.02‬
Price / Book
‪1.63‬
EV / EBITDA
‪8.01‬
Profitability
Profit Margin
‪-21.95%‬
Operating Margin
‪34.72%‬
Return on Assets
‪4.43%‬
Return on Equity
‪-9.38%‬
Ownership
Shares Outstanding
55.01M
Held by Insiders
‪0.24%‬
Held by Institutions
‪50.77%‬
Price stats
Beta
‪0.67‬
50-Day Avg
‪18.04‬
200-Day Avg
‪16.87‬
Dividends
Payout Ratio
‪528.57%‬
Frequency
Quarterly
Analyst Consensus
9 analysts
Market Cap - DHT.UN - DRI Healthcare Trust
Peers - DHT.UN - DRI Healthcare Trust
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on TSX.
Profile Summary - DHT.UN - DRI Healthcare Trust
About
DRI Healthcare Trust is a specialized healthcare investment entity focusing on acquiring, managing, and monetizing pharmaceutical royalties. Its primary function is to provide investors with competitive returns through exposure to revenue streams generated by patented drugs and therapies. By partnering with…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
